AusMedtech has launched the ‘Directory of Known China Advisors’, an online resource designed to help Australian medtech companies pursue partnerships with China.
The Directory is a valuable support hub for Australian medtech companies, providing information and contact details for organisations that have specialist capacity to advise on Chinese partnerships in medtech on areas including:
- Associations, chambers of commerce and industry organisations;
- Austrade contacts;
- Intellectual property advisors;
- Investment and strategic advisors and consultants;
- Regulatory advisors;
- Business and tax consultants.
Launched in the wake of the China-Australia Free Trade Agreement (ChAFTA), which is anticipated to unlock significant business and foreign direct investment opportunities for Australia, the Directory seeks to help local medtech companies leverage the remarkable partnerships opportunities currently.
China ageing population, rising incidences of chronic diseases and the government’s determination to provide healthcare to each of its citizens, coupled the government’s focus on fostering innovation are developing a strong medtech market that is attracting more and more Western biotech companies.
The Directory, providing access to known advisors with specialist knowledge of medtech partnerships in China, aims to provide Australian medtech companies with information and advice that will help in leveraging this valuable opportunity to engage with the China market.
The Directory is the final component of AusBiotech’s “Australian Medical Devices to Asia” project, which seeks to facilitate trade in medical devices with China by providing much-needed information for Australian companies. The project’s preliminary components included a business planning workshop, the Guide for Australian medical technology companies seeking to engage in China and the AusBiotech directory of Australian medtech companies. The project is supported by the Australian Trade and Investment Commission and funded through the Asian Business Engagement (ABE) Plan.*
The ‘Directory of Known China Advisors’ can be found at the AusBiotech website.
Expressions of interest are still open to advisory and consulting organisations known to AusBiotech, please contact email@example.com to find out more.
*The views expressed herein are not necessarily the view of the Commonwealth of Australia, and the Commonwealth does not accept responsibility for any information or advice contained herein.